Richard C. Tenglin

Pregnancies during and after trastuzumab and/or lapatinib in patients with human epidermal growth factor receptor 2–positive early breast cancer: Analysis from the NeoALTTO (BIG 1‐06) and ALTTO (BIG 2‐06) trials

Matteo Lambertini, Samuel Martel, Christine Campbell et al. · Cancer · 2018 · 72 citations · Full text

Medicine, Obstetrics, Oncology +17

Gemcitabine, Cisplatin, and Radiotherapy for Patients With Locally Advanced Pancreatic Adenocarcinoma: Results of the North Central Cancer Treatment Group Phase II Study N9942

Michael G. Haddock, Revathi Swaminathan, Nathan R. Foster et al. · Journal of Clinical Oncology · 2007 · 69 citations · Full text

Medicine, Oncology, Radiation Oncology +13

Results of a Phase II Study of High-Dose Thoracic Radiation Therapy With Concurrent Cisplatin and Etoposide in Limited-Stage Small-Cell Lung Cancer (NCCTG 95-20-53)

Steven E. Schild, James A. Bonner, Shauna L. Hillman et al. · Journal of Clinical Oncology · 2007 · 69 citations

Medicine, Oncology, Radiation Oncology +14

Subcutaneous interleukin-4 (IL-4) for relapsed and resistant non-Hodgkin lymphoma: A phase II trial in the North Central Cancer Treatment Group, NCCTG 91-78-51

David M. Kurtz, Loren K. Tschetter, Jacob B. Allred et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2007 · 23 citations

Medicine, Oncology, Pharmacotherapy +15